These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 8595621

  • 1. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
    Mathew R, Zeballos GA, Tun H, Gewitz MH.
    Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
    [Abstract] [Full Text] [Related]

  • 2. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
    Ozturk EI, Uma S.
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759
    [Abstract] [Full Text] [Related]

  • 3. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Nov; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 4. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B, Cheng YS, Dai DZ, Li N, Zhang TT, Dai Y.
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [Abstract] [Full Text] [Related]

  • 5. CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway.
    Zhang TT, Cui B, Dai DZ, Su W.
    Acta Pharmacol Sin; 2005 Nov; 26(11):1309-16. PubMed ID: 16225752
    [Abstract] [Full Text] [Related]

  • 6. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J, Shimpo H, Shimamoto A, Chong AJ, Hampton CR, Spring DJ, Yada M, Takao M, Onoda K, Yada I, Pohlman TH, Verrier ED.
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [Abstract] [Full Text] [Related]

  • 7. Gender differences in pulmonary arterial reactivity to dilatory agonists in pulmonary hypertension.
    Packer CS, Johnson TC, Vijay P, Sharp TG, Jha D, Tighe SM, Chukwu HV.
    J Gend Specif Med; 2003 Dec; 6(3):30-8. PubMed ID: 14513574
    [Abstract] [Full Text] [Related]

  • 8. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
    Jasmin JF, Mercier I, Dupuis J, Tanowitz HB, Lisanti MP.
    Circulation; 2006 Aug 29; 114(9):912-20. PubMed ID: 16940204
    [Abstract] [Full Text] [Related]

  • 9. Enhanced prostanoid-mediated vasorelaxation in pulmonary arteries isolated during experimental endotoxemia.
    Myers TP, Myers PR, Adams HR, Parker JL.
    Shock; 1999 Jun 29; 11(6):436-42. PubMed ID: 10454834
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
    Nakazawa H, Hori M, Ozaki H, Karaki H.
    Br J Pharmacol; 1999 Nov 29; 128(5):1098-104. PubMed ID: 10556948
    [Abstract] [Full Text] [Related]

  • 11. Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension.
    Mathew R, Gloster ES, Sundararajan T, Thompson CI, Zeballos GA, Gewitz MH.
    J Appl Physiol (1985); 1997 May 29; 82(5):1493-8. PubMed ID: 9134898
    [Abstract] [Full Text] [Related]

  • 12. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
    Kakusaka I, Kaneko N, Kiyatake K, Fujita A, Suzuki A, Nakano K, Okada O, Sugita T, Watanabe S, Kuriyama T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan 29; 27(1):51-6. PubMed ID: 2501548
    [Abstract] [Full Text] [Related]

  • 13. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E, Hongo M, Sakai A, Terasawa F, Takahashi M, Yazaki Y, Kinoshita O, Ikeda U.
    Clin Exp Pharmacol Physiol; 2007 Jul 29; 34(7):594-600. PubMed ID: 17581214
    [Abstract] [Full Text] [Related]

  • 14. Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs.
    Morio Y, Homma N, Takahashi H, Yamamoto A, Nagaoka T, Sato K, Muramatsu M, Fukuchi Y.
    J Vasc Res; 2007 Jul 29; 44(4):325-35. PubMed ID: 17438361
    [Abstract] [Full Text] [Related]

  • 15. JTV-506, a new K(ATP) channel opener, relaxes pulmonary artery isolated from monocrotaline-treated pulmonary hypertensive rats.
    Tsutsumi Y, Makita T, Yamaguchi K, Shibata O, Sumikawa K.
    J Anesth; 2004 Jul 29; 18(3):210-5. PubMed ID: 15290421
    [Abstract] [Full Text] [Related]

  • 16. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB, Paramar AN, Balaraman R.
    Cardiovasc Res; 2005 Apr 01; 66(1):150-61. PubMed ID: 15769458
    [Abstract] [Full Text] [Related]

  • 17. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP, Dai ZK, Huang CH, Yeh JL, Wu BN, Wu JR, Chen IJ.
    Kaohsiung J Med Sci; 2014 Jun 01; 30(6):267-78. PubMed ID: 24835346
    [Abstract] [Full Text] [Related]

  • 18. Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril.
    Liu YH, You Y, Song T, Wu SJ, Liu LY.
    J Cardiovasc Pharmacol; 2007 Aug 01; 50(2):155-61. PubMed ID: 17703131
    [Abstract] [Full Text] [Related]

  • 19. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease.
    Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J.
    N Engl J Med; 1991 May 30; 324(22):1539-47. PubMed ID: 2027358
    [Abstract] [Full Text] [Related]

  • 20. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.
    Vascul Pharmacol; 2006 Dec 30; 45(6):358-67. PubMed ID: 16872912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.